Fourth-quarter profits for
Anika Therapeutics fell 36 percent, despite and 18 percent revenue spike, but full-year 2009 sales and earnings both rise.
Anika Therapeutics Inc. (NSDQ:ANIK) saw fourth-quarter profits plunge 36.3 percent as it paid for an acquisition ...
[Published Mar 18 2010 by MassDevice]